Kimberly-Clark’s 54-Year Dividend Streak Faces Its Biggest Test Yet With $48.7 Billion Kenvue Deal
Kimberly-Clark just raised its dividend for the 54th straight year while simultaneously chasing a nearly $50 billion acquisition, and income investors are now weighing whether a deal of that size can coexist with a payout that costs over $1.6 billion…
Kimberly-Clark (NASDAQ:KMB | KMB Price Prediction) is asking income investors to hold two ideas at once. The company just extended its dividend increase streak to 54 consecutive years with the Q2 2026 declaration, and it is simultaneously working to close a $48.7 billion acquisition of Kenvue (NYSE:KVUE) by the end of 2026. Retirees who own this stock for the check want to know whether one survives the other.
What the Record Actually Shows
The dividend file supports a long, unbroken pattern of annual increases in the quarterly rate. Recent quarters have paid $1.28 per share, up from $1.26 in late 2025 and $1.22 in 2024, with an annualized forward dividend of $5.12 and the next payment scheduled for October 2, 2026. Importantly, the board raised the payout again this year with the Kenvue deal already pending. A board worried about covering its dividend does not typically raise it. Fifty-plus-year streaks are a rare club (we ranked ten of them by valuation in a free Dividend Kings report).
Kenvue Deal Math
Large acquisitions consume cash and frequently add debt, and debt service competes with the dividend for the same free cash flow. Kimberly-Clark enters this transition with $956 million in cash and total debt of roughly $6.52 billion as of June 30, 2026. Full-year 2025 operating cash flow was $2.777 billion against $1.138 billion of capex and $1.66 billion of dividends. That coverage is real, but it is not enormous, and it is before Kenvue-related financing lands on the balance sheet.
CEO Mike Hsu framed the transaction as “a powerful next step in our transformation” and a “unique, generational value creation opportunity.” On the Q2 call, management said it has roughly 50 teams and 600 people working on synergy planning, and told analysts:
“We remain very confident in the total number of synergies.”
Still, the call gave no specific update on leverage, financing structure, free cash flow, or the timing of the next dividend increase.
Flip Side for Income Holders
Kimberly-Clark sells Huggies, Kleenex, Kotex and Scott, categories that grind through recessions. Q2 2026 adjusted EPS of $2.12 beat the $2.01 estimate and adjusted gross margin expanded 190 bps to 38.8%. The stock, however, is down 20.36% over the past year to $98.15, pushing the yield near 5.16%. That yield reflects the market pricing in real risk.
What to Watch
Three items will tell the story: pro forma leverage after Kenvue closes, whether free cash flow continues to cover the roughly $1.66 billion annual dividend outlay, and whether the next scheduled raise arrives on its usual January cadence. If those three line up, the streak keeps going. If any slips, income holders will know the deal changed the math.
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
